Series by David C. Helfgott, MD
A collection of news, case studies, and feature articles focused on the diagnosis and management of infectious processes in patients with immune systems impaired by an underlying disease, such as hematologic malignancies that affect cells crucial to normal host immune response, or weakened secondary to treatments for disease, such as steroids, chemotherapeutic agents, or biologic response modifiers targeting immune mediators.
The risk for infection and malignancy associated with biologic use complicates the management of patients with a deficient immune system. Equip yourself with the information needed to effectively manage these complex patients.
September 15, 2017
Case of a 51-year-old man with Crohn's disease who develops fever and cough after receiving biologic treatment.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Climate Change: Effects on the Incidence and Distribution of Infectious Diseases
- Improving Campaigns Regarding the Value of Adult Vaccines
- Seminal HPV Infection Prevalent Worldwide, May Affect Male Fertility
- Pausing ART to Identify Biomarkers for HIV RNA Rebound: Safety and Ethical Considerations
- MicroRNAs in Infectious Disease: Emerging Clinical Applications
- Efficacy of Direct-Acting Antivirals for HCV Clearance in Older Adults
- SVR Achieved With Sofosbuvir, Grazoprevir/Elbasvir Plus Ribavirin in HCV
- First Oral Smallpox Treatment Submitted to FDA for NDA
- Trends in Meningococcal Disease Following MenACWY Vaccine Introduction
- Clinician Accuracy Evaluated for Lyme Disease